Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 30Terminated 4Recruiting 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Uterine Cervical Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Small Cell Lung Carcinoma 1Sarcoma 1Retinoblastoma 1Prostatic Neoplasms 1Platinum-Refractory Fallopian Tube Carcinoma 1Neuroblastoma 1Neoplasm Metastasis 1Lymphoma 1Lung Neoplasms 1Glioma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Advanced Solid Tumors 1

Interventions

Carboplatin 18Radiotherapy 10Cisplatin 10Pemetrexed 8Paclitaxel 8durvalumab 6Magnetic Resonance Spectroscopy 6Gemcitabine 6Radiosurgery 5Nivolumab 5Etoposide 5pembrolizumab 4atezolizumab 4Surveys and Questionnaires 4Radiation 4Erlotinib Hydrochloride 4Docetaxel 4Taxes 3Standard of Care 3Specimen Handling 3Platinum 3Cetuximab 3Bronchoscopy 3Biopsy 3Bevacizumab 31,2-diaminocyclohexaneplatinum II citrate 3sapanisertib 2etoposide phosphate 2capmatinib 2Vinorelbine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Lung Neoplasms × Topotecan × Clear all
NCT00006374 2014-01-15

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Case Comprehensive Cancer Center

Phase 2 Withdrawn
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡